FGFR1 and non-small cell lung carcinoma: In particular, 19 patients representing ∼0.17% (19/10,966) of the NSCLC population were identified with FGFR1-4 oncogenic or likely oncogenic mutations according to the OncoKB database19 (Figure 1D, Table 1, and Supplementary Table S1).